Cargando…
Downregulation of LINC01508 contributes to cisplatin resistance in ovarian cancer via the regulation of the Hippo-YAP pathway
BACKGROUND: Some long non-coding RNAs (lncRNAs) have been found to contribute to cisplatin resistance. Here, we identified a novel lncRNA that was downregulated in cisplatin-resistant to ovarian cancer (OC) cells and aimed to examine the contribution of LINC01508 to cisplatin resistance in OC cells....
Autores principales: | Xiao, Lan, Shi, Xiao-Yan, Li, Ze-Lian, Li, Min, Zhang, Min-Min, Yan, Shi-Jie, Wei, Zhao-Lian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362814/ https://www.ncbi.nlm.nih.gov/pubmed/34132072 http://dx.doi.org/10.3802/jgo.2021.32.e77 |
Ejemplares similares
-
Proton pump inhibitors can reverse the YAP mediated paclitaxel resistance in epithelial ovarian cancer
por: He, Jing, et al.
Publicado: (2019) -
YAP induces cisplatin resistance through activation of autophagy in human ovarian carcinoma cells
por: Xiao, Lan, et al.
Publicado: (2016) -
Down regulation of lincRNA-p21 contributes to gastric cancer development through Hippo-independent activation of YAP
por: Chen, Ying, et al.
Publicado: (2017) -
LncRNA modulates Hippo-YAP signaling to reprogram iron metabolism
por: He, Xin-yu, et al.
Publicado: (2023) -
YAP and the Hippo pathway in cholangiocarcinoma
por: Sugihara, Takaaki, et al.
Publicado: (2019)